Meet the Experts
Yale University, New Haven, CT; Central Connecticut Dermatology Research, Cromwell, CT, USA
Bruce Strober is Assistant Clinical Professor of Dermatology at Yale University in New Haven, Connecticut. He received his medical and graduate degrees from Columbia University College of Physicians and Surgeons, New York, and completed his postgraduate training in dermatology at New York University.
Dr Strober is board certified by the American Board of Dermatology and is a Fellow of the American Academy of Dermatology. He currently serves on the board of the International Psoriasis Council, and is Scientific Director of the Corrona/NPF Psoriasis Patient Registry. He has authored numerous journal articles and has spoken extensively to both physician and patient audiences in the field of dermatology.
Dr Strober also sees patients at his practice, Central Connecticut Dermatology Research, where he specializes in complex medical dermatology.
Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA
Kenneth Gordon is Thomas J Russell Family/Milwaukee Community Dermatologists Professor and Chair of Dermatology at the Medical College of Wisconsin, Milwaukee.
Previously Dr Gordon served as Professor of Dermatology at Northwestern University, Feinberg School of Medicine (Chicago) and Associate Director, Center for Clinical Research of Northwestern University Center for Clinical and Translational Science.
Dr Gordon received his medical degree from Columbia University, New York. In his position as a member of the American Academy of Dermatology (AAD), Dr Gordon has chaired several sessions at the annual meeting, and is on the Working Group on Psoriasis and Psoriatic Arthritis.
Dr Gordon has published widely in several journals including Journal of the American Academy of Dermatology and The Lancet, and he is a reviewer for others, such as British Journal of Dermatology and The New England Journal of Medicine. His main research interests are therapies for psoriasis and psoriatic arthritis, and he contributed to the development of the AAD treatment guidelines for these diseases.
University Medical Center Hamburg-Eppendorf; Skinflammation Center®, Hamburg; Dermatologikum Berlin, Berlin, Germany
Kristian Reich is Professor for Translational Research in Inflammatory Skin Diseases at the Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf. He is founder and medical director of Skinflammation®, Hamburg, a center specialized in clinical research, patient care and medical education. Since 2013 he is also partner at the Dermatologikum Berlin.
Dr Reich's main research interests include genetic and immunologic mechanisms of cutaneous inflammation and cancer, translational health care research in psoriasis and atopic dermatitis, and the development of new therapies for skin diseases. He has published more than 300 articles in international peer-reviewed journals, among them The Lancet, The New England Journal of Medicine, The Journal of Immunology and The Journal of Allergy and Clinical Immunology. Dr Reich chairs the scientific committee of the German Psoriasis Registry PsoBest, is member of the board of PsoNet e.V. and the ProDerma foundation Hamburg and member of the board of trustees of the Alfred-Marchionini foundation. He is counselor of the International Psoriasis Council and the International Eczema Council.
Dr Reich has received numerous prizes and awards, including the Herbert-Herxheimer Research Prize of the German Society for Immunology and Allergology (2003), the RK Schachter Lectureship (2012), and the Stars of the Academy Award of the American Academy of Dermatology (2016).
Department of Medicine, Dalhousie University, Halifax, NS, Canada
Richard Langley is Professor and Director of Research in the Division of Dermatology, Department of Medicine at Dalhousie University in Canada, and was President of the Canadian Dermatology Association in 2014.
Dr Langley received his undergraduate degree at Dalhousie University, internship in internal medicine, and fellowship in dermatologic surgery at the University of Toronto, Canada, and completed his fellowship training at Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Following his training, Dr Langley joined the Faculty of Medicine at Harvard Medical School, and was Director of Clinical Investigations Unit at Massachusetts General Hospital until June 2000.
Dr Langley has authored over 300 articles, book chapters, and other publications and he is a regular reviewer for several medical and dermatology journals. He is a principal investigator and has conducted over 250 Phase 1–3 studies involving most of the biologic agents in psoriasis and new immunotherapies in atopic dermatitis. He also has an imaging laboratory that has helped pioneer the application of diagnostic in vivo confocal microscopy in benign and malignant melanocytic lesions.
Our partners are supported by an extensive network of global experts working in academia and community-based practices, providing both evidence-based and pragmatic perspectives.